Loading
Finance
4 min read
Areas of Expertise :
Securities, Risk Management, Regulatory Compliance, Corporate Governance, Investments
Published Date:
Last Modified Date:
Jurisdiction:
Federal. Southern District of New York
The case of United States v. Archegos Capital Management LP and Bill Hwang involves a high-profile financial litigation centered on investment risk, derivative trading, and compliance failures. Archegos, a private investment firm structured as a family office by Bill Hwang, experienced a rapid collapse in March 2021 after making large leveraged bets through total return swaps. The incident led to significant financial losses for several global institutions. In April 2022, federal prosecutors charged Hwang and CFO Patrick Halligan with racketeering conspiracy, securities fraud, and wire fraud. The case continues to explore legal questions related to risk disclosure, systemic financial risk, and regulatory oversight.
Archegos Capital Management defaulted on margin calls from banks such as Credit Suisse, Nomura, and Goldman Sachs. The firm had accumulated highly concentrated equity positions using total return swaps, amplifying its exposure. As underlying stock prices fell, Archegos was unable to meet collateral requirements, triggering rapid liquidation of its positions. This contributed to billions of dollars in counterparty losses and raised regulatory concerns about hidden leverage and transparency in private investment operations.
The U.S. Department of Justice filed criminal charges against Bill Hwang and Patrick Halligan, alleging a coordinated scheme to misrepresent Archegos’ financial condition to lenders. The charges include racketeering conspiracy and securities fraud. Prosecutors claimed that Archegos presented inaccurate information regarding its holdings and market exposure to secure favorable financing. The indictment highlighted the potential systemic risks posed by opaque trading practices and limited regulatory reporting requirements for family offices.
The case advanced through a series of pre-trial motions, discovery exchanges, and procedural challenges. Defense counsel questioned the validity of the government’s fraud claims and argued that Archegos’ trades were lawful under existing financial regulations. Federal prosecutors emphasized repeated misstatements made to financial institutions and presented data to support allegations of intentional market manipulation. Legal observers noted that the outcome could influence future oversight of leveraged trading conducted through non-traditional investment vehicles.
Trial proceedings began in the U.S. District Court for the Southern District of New York. Key witnesses, including former employees and compliance officers, testified about internal decision-making, risk practices, and communications with external counterparties. Expert witnesses presented technical evidence related to swap agreements, financial leverage, and counterparty risk. The court focused on evaluating whether Archegos’ representations met legal standards for transparency and compliance.
As of 2025, the case remains in progress with continued testimony from financial experts and market analysts. Testimony has centered on investment compliance, derivative exposure, and the adequacy of internal risk controls. The proceedings are expected to shape interpretations of securities law and influence how financial firms disclose exposure to complex instruments such as swaps.
Court:
United States District Court for the Southern District of New York
Case Name:
United States v. Archegos Capital Management LP and Bill Hwang
Derivatives
Securities Fraud
Securities Litigation
Internal Controls
Financial Fraud
Trading
The case of United States v. Archegos Capital Management LP and Bill Hwang involves a high-profile financial litigation centered on investment risk, derivative trading, and compliance failures. Archegos, a private investment firm structured as a family office by Bill Hwang, experienced a rapid collapse in March 2021 after making large leveraged bets through total return swaps. The incident led to significant financial losses for several global institutions. In April 2022, federal prosecutors charged Hwang and CFO Patrick Halligan with racketeering conspiracy, securities fraud, and wire fraud. The case continues to explore legal questions related to risk disclosure, systemic financial risk, and regulatory oversight.
Archegos Capital Management defaulted on margin calls from banks such as Credit Suisse, Nomura, and Goldman Sachs. The firm had accumulated highly concentrated equity positions using total return swaps, amplifying its exposure. As underlying stock prices fell, Archegos was unable to meet collateral requirements, triggering rapid liquidation of its positions. This contributed to billions of dollars in counterparty losses and raised regulatory concerns about hidden leverage and transparency in private investment operations.
The U.S. Department of Justice filed criminal charges against Bill Hwang and Patrick Halligan, alleging a coordinated scheme to misrepresent Archegos’ financial condition to lenders. The charges include racketeering conspiracy and securities fraud. Prosecutors claimed that Archegos presented inaccurate information regarding its holdings and market exposure to secure favorable financing. The indictment highlighted the potential systemic risks posed by opaque trading practices and limited regulatory reporting requirements for family offices.
The case advanced through a series of pre-trial motions, discovery exchanges, and procedural challenges. Defense counsel questioned the validity of the government’s fraud claims and argued that Archegos’ trades were lawful under existing financial regulations. Federal prosecutors emphasized repeated misstatements made to financial institutions and presented data to support allegations of intentional market manipulation. Legal observers noted that the outcome could influence future oversight of leveraged trading conducted through non-traditional investment vehicles.
Trial proceedings began in the U.S. District Court for the Southern District of New York. Key witnesses, including former employees and compliance officers, testified about internal decision-making, risk practices, and communications with external counterparties. Expert witnesses presented technical evidence related to swap agreements, financial leverage, and counterparty risk. The court focused on evaluating whether Archegos’ representations met legal standards for transparency and compliance.
As of 2025, the case remains in progress with continued testimony from financial experts and market analysts. Testimony has centered on investment compliance, derivative exposure, and the adequacy of internal risk controls. The proceedings are expected to shape interpretations of securities law and influence how financial firms disclose exposure to complex instruments such as swaps.
While specific expert witnesses have not been publicly disclosed, several types of experts would be well-suited to provide critical insights in a case involving financial risk, compliance, and governance.
Could evaluate how a firm’s internal oversight structure aligns with fiduciary obligations and regulatory expectations.
Would help explain complex instruments like total return swaps and how leverage impacts institutional exposure.
Could assess the extent to which representations to counterparties complied with federal securities laws and industry standards.
Would offer analysis of the effectiveness of internal risk management systems and policies in high-volume trading environments.
The case highlights the need to monitor entities that operate outside conventional regulatory frameworks but may engage in high-risk activities.
Litigators should track developments in disclosure obligations related to derivatives and leveraged financial products.
Internal governance failures can lead to significant legal liability, especially when dealing with systemic exposures.
Effective use of expert witnesses is crucial in helping courts understand complex financial strategies and regulatory implications.
U.S. v. Archegos Capital Management LP and Bill Hwang represents a significant business litigation case involving financial compliance, risk oversight, and trading practices. As proceedings continue into 2025, the trial underscores ongoing concerns about market transparency, institutional accountability, and the legal framework governing private investment firms. Expert testimony plays a key role in clarifying technical concepts and guiding judicial understanding in high-stakes financial cases.
What is Archegos Capital Management?
Archegos was a family office investment firm that managed Bill Hwang’s capital, employing leveraged strategies using total return swaps to build positions in publicly traded companies.
Why is this case important in business law?
The case raises legal and regulatory questions about derivative trading, financial risk disclosure, and the oversight of non-traditional investment structures.
What legal violations are alleged?
The government has charged Archegos’ executives with racketeering conspiracy, securities fraud, and wire fraud based on alleged misrepresentations to financial institutions.
What types of experts are involved in the case?
Although not publicly identified, expert testimony has reportedly involved professionals in financial risk, governance, compliance, and securities regulation.
Has the case reached a verdict?
No. The trial began in 2024 and remains ongoing in 2025, with testimony and evidence still being presented in federal court.
While specific expert witnesses have not been publicly disclosed, several types of experts would be well-suited to provide critical insights in a case involving financial risk, compliance, and governance.
Could evaluate how a firm’s internal oversight structure aligns with fiduciary obligations and regulatory expectations.
Would help explain complex instruments like total return swaps and how leverage impacts institutional exposure.
Could assess the extent to which representations to counterparties complied with federal securities laws and industry standards.
Would offer analysis of the effectiveness of internal risk management systems and policies in high-volume trading environments.
The case highlights the need to monitor entities that operate outside conventional regulatory frameworks but may engage in high-risk activities.
Litigators should track developments in disclosure obligations related to derivatives and leveraged financial products.
Internal governance failures can lead to significant legal liability, especially when dealing with systemic exposures.
Effective use of expert witnesses is crucial in helping courts understand complex financial strategies and regulatory implications.
U.S. v. Archegos Capital Management LP and Bill Hwang represents a significant business litigation case involving financial compliance, risk oversight, and trading practices. As proceedings continue into 2025, the trial underscores ongoing concerns about market transparency, institutional accountability, and the legal framework governing private investment firms. Expert testimony plays a key role in clarifying technical concepts and guiding judicial understanding in high-stakes financial cases.
What is Archegos Capital Management?
Archegos was a family office investment firm that managed Bill Hwang’s capital, employing leveraged strategies using total return swaps to build positions in publicly traded companies.
Why is this case important in business law?
The case raises legal and regulatory questions about derivative trading, financial risk disclosure, and the oversight of non-traditional investment structures.
What legal violations are alleged?
The government has charged Archegos’ executives with racketeering conspiracy, securities fraud, and wire fraud based on alleged misrepresentations to financial institutions.
What types of experts are involved in the case?
Although not publicly identified, expert testimony has reportedly involved professionals in financial risk, governance, compliance, and securities regulation.
Has the case reached a verdict?
No. The trial began in 2024 and remains ongoing in 2025, with testimony and evidence still being presented in federal court.
Derivatives
Securities Fraud
Securities Litigation
Internal Controls
Financial Fraud
Trading
Broker, +4
Finance
Forensic Accounting, +4
Finance